These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30031084)

  • 1. Diethylaminoethyl- chitosan as an efficient carrier for siRNA delivery: Improving the condensation process and the nanoparticles properties.
    de Souza RHFV; Picola IPD; Shi Q; Petrônio MS; Benderdour M; Fernandes JC; Lima AMF; Martins GO; Martinez Junior AM; de Oliveira Tiera VA; Tiera MJ
    Int J Biol Macromol; 2018 Nov; 119():186-197. PubMed ID: 30031084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan derivatives for gene transfer: effect of phosphorylcholine and diethylaminoethyl grafts on the in vitro transfection efficiency.
    Picola IP; Shi Q; Fernandes JC; Petrônio MS; Lima AM; de Oliveira Tiera VA; Tiera MJ
    J Biomater Sci Polym Ed; 2016 Nov; 27(16):1611-30. PubMed ID: 27532422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo therapeutic efficacy of TNFα silencing by folate-PEG-chitosan-DEAE/siRNA nanoparticles in arthritic mice.
    Shi Q; Rondon-Cavanzo EP; Dalla Picola IP; Tiera MJ; Zhang X; Dai K; Benabdoune HA; Benderdour M; Fernandes JC
    Int J Nanomedicine; 2018; 13():387-402. PubMed ID: 29391796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphipathic chitosans improve the physicochemical properties of siRNA-chitosan nanoparticles at physiological conditions.
    Martins GO; Segalla Petrônio M; Furuyama Lima AM; Martinez Junior AM; de Oliveira Tiera VA; de Freitas Calmon M; Leite Vilamaior PS; Han SW; Tiera MJ
    Carbohydr Polym; 2019 Jul; 216():332-342. PubMed ID: 31047074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PEGylated carboxymethyl chitosan/calcium phosphate hybrid anionic nanoparticles mediated hTERT siRNA delivery for anticancer therapy.
    Xie Y; Qiao H; Su Z; Chen M; Ping Q; Sun M
    Biomaterials; 2014 Sep; 35(27):7978-91. PubMed ID: 24939077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
    Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
    Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
    Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
    J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of diethylethylamine-chitosan for gene delivery: composition effects on the in vitro transfection efficiency.
    de Paula Pansani Oliveira F; Dalla Picola IP; Shi Q; Barbosa HF; Tiera VA; Fernandes JC; Tiera MJ
    Nanotechnology; 2013 Feb; 24(5):055101. PubMed ID: 23306549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence Supporting the Safety of Pegylated Diethylaminoethyl-Chitosan Polymer as a Nanovector for Gene Therapy Applications.
    Rondon EP; Benabdoun HA; Vallières F; Segalla Petrônio M; Tiera MJ; Benderdour M; Fernandes JC
    Int J Nanomedicine; 2020; 15():6183-6200. PubMed ID: 32922001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
    Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
    Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
    Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
    Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity.
    Holzerny P; Ajdini B; Heusermann W; Bruno K; Schuleit M; Meinel L; Keller M
    J Control Release; 2012 Jan; 157(2):297-304. PubMed ID: 21884740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nebulised siRNA encapsulated crosslinked chitosan nanoparticles for pulmonary delivery.
    Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
    Int J Pharm; 2013 Oct; 455(1-2):241-7. PubMed ID: 23876499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-based therapeutic nanoparticles for combination gene therapy and gene silencing of in vitro cell lines relevant to type 2 diabetes.
    Jean M; Alameh M; De Jesus D; Thibault M; Lavertu M; Darras V; Nelea M; Buschmann MD; Merzouki A
    Eur J Pharm Sci; 2012 Jan; 45(1-2):138-49. PubMed ID: 22085632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced siRNA delivery and silencing gold-chitosan nanosystem with surface charge-reversal polymer assembly and good biocompatibility.
    Han L; Zhao J; Zhang X; Cao W; Hu X; Zou G; Duan X; Liang XJ
    ACS Nano; 2012 Aug; 6(8):7340-51. PubMed ID: 22838646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of hypoxia inducible factor-1α small interfering RNA and 5-fluorouracil to overcome drug resistance in gastric cancer SGC-7901 cells.
    Chen Y; Sun L; Guo D; Wu Z; Chen W
    J Gene Med; 2017 Dec; 19(12):. PubMed ID: 29106062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of chitosan nanoparticles as an anti-HIV siRNA delivery vehicle.
    Iranpur Mobarakeh V; Modarressi MH; Rahimi P; Bolhassani A; Arefian E; Atyabi F; Vahabpour R
    Int J Biol Macromol; 2019 May; 129():305-315. PubMed ID: 30738164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.